ØCD: protocol for the development and evaluation of a cognitive-behavioral prevention program for obsessive-compulsive disorder.
Roxana A I Cardoș, Elisa P Dumitru, Oana A David
https://pubmed.ncbi.nlm.nih.gov/38724961Actively Recruiting
Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID06262464
The Efficacy of an OCD Prevention Programme for at Risk Adults: a Randomized Clinical Trial
Led by Babes-Bolyai University · Updated on 2025-04-18
200
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
Sponsors
B
Babes-Bolyai University
Lead Sponsor
R
Romanian National Authority for Scientific Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a prevention program for adults at risk of developing Obsessive-Compulsive Disorder (OCD) in a randomized clinical trial. The study aims to test whether this program can effectively reduce OCD symptoms and serve as a form of tertiary prevention. The trial is sponsored by Babes-Bolyai University and includes adults aged 18 to 65 years. Participants will be randomly assigned to one of two groups. The experimental group will take part in a two-week OCD prevention program consisting of six online group sessions using cognitive and behavioral strategies to lower OCD risk factors and related symptoms. The control group will receive treatment as usual and will not participate in the prevention program. During the study, participants will be assessed at baseline and after two weeks to measure changes in OCD symptoms, depression, and anxiety using standardized scales. Additional evaluations will assess changes in experiential avoidance, cognitive distortions, intolerance of uncertainty, and resilience. The study is double-blinded, and participants will be monitored for these outcomes throughout the intervention period.
CONDITIONS
Brief Title
An OCD Prevention Programme for at Risk Adults
Who Can Participate
Age: 18Years - 65Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Age over 18 years
You will not qualify if you...
- Clinically diagnosed OCD
- Current psychiatric or psychotherapeutic treatment
- Diagnosis of a personality disorder
- Suicidal ideation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or online) for eligibility assessment and informed consent
Outpatient Treatment
Duration - 2 weeks
Participants in the experimental group attend a cognitive-behavioral OCD prevention program consisting of group sessions. Participants in the control group receive treatment as usual without additional intervention.
6 group sessions (online) over two weeks, 3 sessions per week
Trial Site Locations
Total: 1 location
1
Babes-Bolyai University, Faculty of Psychology and Educational Sciences, Department of Clinical Psychology and Psychotherapy
Cluj-Napoca, Romania, Romania, 400015
Actively Recruiting
Loading map...
Research Team
R
Roxana Cardoș, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here